If a drug name is misspelled on a DEA 222 form, can the supplier still fill the order?

A misspelling of a drug name on a DEA 222 form allows the supplier to fill the order as long as the intent and identity of the drug can still be clearly determined. The DEA regulations provide flexibility in cases where the error does not lead to medication errors or confusion about which substance is being ordered.

When suppliers receive a DEA 222 form, they are responsible for ensuring that the order corresponds with valid prescriptions and the specified drugs. If the misspelling can be easily recognized and does not compromise the integrity of the order, it can still be processed. The key factor here is the clarity of the order's intention—if the specific drug is identifiable despite the misspelling, the supplier can go ahead and fulfill the request.

In practice, this means that while careful attention to detail is necessary in handling controlled substances, minor errors such as a misspelled drug name can often be overlooked if they do not prevent the identification of what is being ordered.